Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 7/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7155412 | 1.00 | SLC5A2 (0.53) | SLC5A2CYP3A4CYP2D6MAPTCYP2C19 | |
| SCHEMBL2384795 | 0.90 | SLC5A2 (0.45) | SLC5A2CYP3A4CYP2D6MAPTCYP2C19 | |
| SCHEMBL13590060 | 0.90 | SLC5A2 (0.45) | SLC5A2CYP3A4CYP2D6MAPTCYP2C19 | |
| SCHEMBL10590087 | 0.90 | SLC5A2 (0.45) | SLC5A2CYP3A4CYP2D6MAPTCYP2C19 | |
| SCHEMBL7154382 | 0.84 | SLC5A2 (0.41) | SLC5A2CYP3A4CYP2D6MAPTCYP2C19 | |
| SCHEMBL31135220 | 0.84 | SLC5A2 (0.41) | SLC5A2CYP3A4CYP2D6MAPTCYP2C19 | |
| SCHEMBL9809652 | 0.84 | SLC5A2 (0.43) | SLC5A2 | |
| SCHEMBL7152153 | 0.83 | SLC5A2 (0.46) | SLC5A2CYP3A4CYP2D6MAPTCYP2C19 | |
| SCHEMBL7616740 | 0.83 | SLC5A2 (0.42) | SLC5A2CYP3A4CYP2D6MAPTCYP2C19 | |
| SCHEMBL468525 | 0.82 | SLC5A2 (0.43) | SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8231884-B2 | Polymer or surfactant enveloping oriented fibers; mass formed by 3:2,4-di-O-benzylidene-D-sorbitol organogelator; oblong particles have beneficial iridescent properties; soft-focus effect properties; make-up and foundation improve visual appearance of skin | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2012-07-31 | — | — | US | claimed |
| US-20080248071-A1 | Diffusing Particles Based on Organogelling Xerogel Fibers, Method for Preparing Same and Use in Cosmetic Formulations | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2008-10-09 | — | — | US | claimed |
| US-8231884-B2 | Polymer or surfactant enveloping oriented fibers; mass formed by 3:2,4-di-O-benzylidene-D-sorbitol organogelator; oblong particles have beneficial iridescent properties; soft-focus effect properties; make-up and foundation improve visual appearance of skin | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2012-07-31 | — | — | US | disclosed |
| US-20080248071-A1 | Diffusing Particles Based on Organogelling Xerogel Fibers, Method for Preparing Same and Use in Cosmetic Formulations | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2008-10-09 | — | — | US | disclosed |
| EP-1928403-A1 | DIFFUSING PARTICLES BASED ON ORGANOGELLING XEROGEL FIBERS, METHOD FOR PREPARING SAME AND USE IN COSMETIC FORMULATIONS | Pierre Fabre Dermo-Cosmetique (FR) | 2008-06-11 | — | — | EP | disclosed |
| WO-2007039561-A1 | DIFFUSING PARTICLES BASED ON ORGANOGELLING XEROGEL FIBERS, METHOD FOR PREPARING SAME AND USE IN COSMETIC FORMULATIONS | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2007-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080248071-A1 | Diffusing Particles Based on Organogelling Xerogel Fibers, Method for Preparing Same and Use in Cosmetic Formulations | SORD, DPM1, SUCLG1 | SLC5A2 1924/4885CYP3A4 4210/4885CYP2D6 520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.